Literature DB >> 15299197

Expression of cyclooxygenase-2 and thromboxane synthase in non-neoplastic and neoplastic thyroid lesions.

Mary B Casey1, Shuya Zhang, Long Jin, Sabine Kajita, Ricardo V Lloyd.   

Abstract

Cyclooxygenase-2 (COX-2) and thromboxane synthase (TBXAS) are important enzymes involved in the arachidonic acid pathway and synthesis of prostaglandins. We examined COX-2 and TBXAS immunoreactivity in 150 surgically resected thyroid specimens using immunohistochemistry to determine expression in benign and malignant thyroid lesions and to examine their roles in thyroid tumor progression. Papillary thyroid carcinomas and follicular carcinomas expressed higher levels of COX-2 compared to follicular adenomas and adenomatous nodules. We showed for the first time that TBXAS was expressed in thyroid tissues, with higher levels in papillary carcinomas compared to non-neoplastic and benign thyroid tissues. Western blot was performed on seven thyroid samples. These results indicate that both COX-2 and TBXAS are expressed in benign and malignant thyroid tissues. Although some malignant thyroid tumors showed higher levels of COX-2 expression, COX-2 and TBXAS are probably not useful in the immunohistochemical diagnosis of thyroid malignancies. However, the expression of both COX-2 and TBXAS by thyroid tissue may provide insight into the role of these enzymes in progression from benign to malignant thyroid tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15299197     DOI: 10.1385/ep:15:2:107

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  46 in total

1.  Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.

Authors:  M K Jones; H Wang; B M Peskar; E Levin; R M Itani; I J Sarfeh; A S Tarnawski
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  The porcine thromboxane synthase-encoding cDNA: sequence, mRNA expression and enzyme production in Sf9 insect cells.

Authors:  R F Shen; L Zhang; S J Baek; H H Tai; K D Lee
Journal:  Gene       Date:  1994-03-25       Impact factor: 3.688

Review 3.  Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.

Authors:  S Moncada; J R Vane
Journal:  Drug Ther       Date:  1982

4.  Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.

Authors:  T O Daniel; H Liu; J D Morrow; B C Crews; L J Marnett
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

5.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

Authors:  T Hida; Y Yatabe; H Achiwa; H Muramatsu; K Kozaki; S Nakamura; M Ogawa; T Mitsudomi; T Sugiura; T Takahashi
Journal:  Cancer Res       Date:  1998-09-01       Impact factor: 12.701

6.  Host cyclooxygenase-2 modulates carcinoma growth.

Authors:  C S Williams; M Tsujii; J Reese; S K Dey; R N DuBois
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas.

Authors:  M Kömhoff; Y Guan; H W Shappell; L Davis; G Jack; Y Shyr; M O Koch; S B Shappell; M D Breyer
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

8.  Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.

Authors:  O N Tucker; A J Dannenberg; E K Yang; F Zhang; L Teng; J M Daly; R A Soslow; J L Masferrer; B M Woerner; A T Koki; T J Fahey
Journal:  Cancer Res       Date:  1999-03-01       Impact factor: 12.701

9.  Chromogranin a processing in human pituitary adenomas and carcinomas: analysis with region-specific antibodies.

Authors:  Long Jin; Shuya Zhang; Jill Bayliss; Bernd Scheithauer; Xiang Qian; Ikuo Kobayashi; Mats Stridsberg; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

10.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

Authors:  M Tsujii; S Kawano; R N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more
  9 in total

1.  Diagnostic utility of immunohistochemical panel in various thyroid pathologies.

Authors:  Arturs Ozolins; Zenons Narbuts; Ilze Strumfa; Guna Volanska; Janis Gardovskis
Journal:  Langenbecks Arch Surg       Date:  2010-07-18       Impact factor: 3.445

Review 2.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 3.  Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

Authors:  Onder Onguru; Mary B Casey; Sabine Kajita; Nobuki Nakamura; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

4.  Cyclooxygenase 1 and 2 expressions in the human thyroid gland.

Authors:  Heung-Man Lee; Seung-Kuk Baek; Soon-Young Kwon; Kwang-Yoon Jung; Sung-Won Chae; Soon-Jae Hwang; Jeong-Soo Woo; June-Young Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-12-16       Impact factor: 2.503

Review 5.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

6.  Morphoproteomic confirmation of an activated nuclear factor-кBp65 pathway in follicular thyroid carcinoma.

Authors:  Jing Liu; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

Review 7.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

8.  Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.

Authors:  Constantinos Giaginis; Paraskevi Alexandrou; Ioanna Delladetsima; Ioannis Karavokyros; Eugene Danas; Athina Giagini; Efstratios Patsouris; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2016-01       Impact factor: 3.201

9.  Assessment of cyclooxygenase-1 and 2 gene expression levels in chronic autoimmune thyroiditis, papillary thyroid carcinoma and nontoxic nodular goitre.

Authors:  Kinga Krawczyk-Rusiecka; Katarzyna Wojciechowska-Durczynska; Anna Cyniak-Magierska; Arkadiusz Zygmunt; Andrzej Lewinski
Journal:  Thyroid Res       Date:  2014-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.